Autologous HSC transplantation following ex vivo gene therapy employing third-generation lentiviruses is ongoing in a number of clinical trials for Wiskott-Aldrich syndrome, ADA severe combined immunodeficiency (ADA-SCID), X-linked SCID, and chronic granulomatous disease (CGD). The gene discussed is ADA; the disease is severe combined immunodeficiency.